Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
MYLkQ2hF9LkVCyjA
